Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis.
Singal AG, Pillai A, Tiro J. · 2014
Read Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis. by Singal AG, Pillai A, Tiro J. (2014) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3972088.txt.
Description
Amit G. Singal, Anjana Pillai, and Jasmin Tiro pool the evidence on scanning patients with liver scarring for early liver cancer, in PLoS Medicine in 2014. Hepatocellular carcinoma is the third leading cause of cancer death worldwide, and it grows out of cirrhosis. Caught early, it can be cured by transplant or surgery with five-year survival near 70 percent; caught late, median survival is under a year. Guidelines advise twice-yearly ultrasound checks, but the supporting trial evidence in cirrhosis was thin.
Across the studies reviewed, patients under surveillance were more often found at an early, curable stage, more often received curative treatment, and survived longer overall. Early detection and curative treatment rates moved together across studies. The authors note study limitations but conclude the chain from scanning to survival is supported at each link.
Catalog record
| CREATOR | Singal AG, Pillai A, Tiro J. |
|---|---|
| YEAR | 2014 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 54 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |